Within the scope of the investigation, which was conducted about Bilim İlaç Sanayii ve Ticaret AŞ and Drogsan İlaçları Sanayi ve Ticaret AŞ according to the Competition Board decision dated  21.02.2024 and no 24-09/165-M in order to determine whether they violated article 4 of the Act no 4054 on the Protection of Competition (the Act no 4054), as a result of the settlement texts sent by Bilim İlaç Sanayii ve Ticaret AŞ and Drogsan İlaçları Sanayi ve Ticaret AŞ based on the Board’s interim decisions, on the grounds that they made no-poach agreements in the labor market, thus violated article 4 of the Act no 4054, it was decided that per the Competition Board decision dated 15.08.2024 and no 24-33/782-329, Bilim İlaç Sanayii ve Ticaret AŞ shall be imposed 155.488.332,29-TL, per the Competition Board decision dated 15.08.2024 and no 24-33/807-341, Drogsan İlaçları Sanayi ve Ticaret AŞ shall be imposed 30.593.234,79-TL administrative fines and the investigation, which was conducted according to the Board decision dated 21.02.2024 and no 24-09/165-M, shall be terminated with settlement in terms of the said undertakings.

As known, previously, under the scope of the same investigation, it was decided that GlaxoSmithKline İlaçları Sanayi ve Ticaret AŞ shall be fined 33.321.564,11-TL and Abdi İbrahim İlaç Sanayi ve Ticaret AŞ shall be fined 184.363.976,71-TL and the investigation would be terminated with settlement for the undertakings in question as well.